생명과학회지 (Journal of Life Science)

  • 제28권8호
  • /
  • Pages.945-954
  • /
  • 2018
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

인체 혀의 편평세포암 세포에서 ω3-fatty acid desaturase 유전자 발현이 침윤 및 종양형성에 미치는 영향

Effect of ω3-Fatty Acid Desaturase Gene Expression on Invasion and Tumorigenicity in Human Tongue Squamous Cell Carcinoma Cells

  • 홍태화 (충남대학교 의과대학 생화학교실) ;
  • 신소연 (충남대학교 의과대학 생화학교실) ;
  • 한승현 (충남대학교 의과대학 생화학교실) ;
  • 황병두 (충남대학교 의과대학 생화학교실) ;
  • 임규 (충남대학교 의과대학 생화학교실)
  • Hong, Tae-Hwa (Department of Biochemisty, College of Medicine, Chungnam National University) ;
  • Shin, Soyeon (Department of Biochemisty, College of Medicine, Chungnam National University) ;
  • Han, Seung-Hyeon (Department of Biochemisty, College of Medicine, Chungnam National University) ;
  • Hwang, Byung-Doo (Department of Biochemisty, College of Medicine, Chungnam National University) ;
  • Lim, Kyu (Department of Biochemisty, College of Medicine, Chungnam National University)
  • 투고 : 2018.04.06
  • 심사 : 2018.05.08
  • 발행 : 2018.08.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

오메가-3 지방산(오메가-3)은 수종의 암에 대해 종양형성 억제 및 침윤이 억제됨이 알려져 있다. 그러나 혀의 편평세포암 세포에서 내인성 오메가-3에 의한 침윤 및 종양형성 억제 대한 연구가 명확하게 보고된 바 없다. 이에 본 연구는 혀의 편평세포암 세포에서 ${\omega}3$-fatty acid desaturase의 유전자 발현이 침윤 및 종양형성에 미치는 영향을 규명하였다. 먼저 SCC-4 및 SCC-9세포의 침윤능은 오메가-3인 DHA 처리에 의해 억제 됨을 확인 하였다. DHA 처리 후 MMP-9 및 MMP-2 활성이 감소 되었을 뿐만 아니라 그 promoter의 reporter 활성도 억제하였다. 또한 COX-2 및 VEGF promoter 활성 뿐만 아니라 NF-kB 활성도 DHA에 의해 억제 되었다. SCC-9의 ${\omega}3$-desaturase 유전자 stable 세포(fSCC-9sc)의 세포증식 및 colony formation이 억제 되었으며, in vivo 동물실험에서 fSCC-9sc 세포의 종양형성능은 현저히 억제 되었고, 면역형광염색법을 이용한 fSCC-9sc 세포의 종양 조직에서의 TUNEL 양성세포는 대조군인 fSCC-9cc 세포에 비해 현저히 증가하였다. 이상의 결과로 오메가-3는 인체 혀의 편평세포암 세포의 침윤 뿐만 아니라 종양형성을 억제하여 항암작용을 나타낼 수 있으며 따라서 오메가-3는 인체 혀의 편평암의 예방 및 치료에 유용하게 사용될 수 있으리라 생각된다.

Omega-3 polyunsaturated fatty acids (${\omega}3$-fatty acid) have been found to possess anticancer properties in a variety of cancer cell lines and animal models, but their effects in human tongue squamous cell carcinomas (SCCs) remain unclear. This study was designed to examine the effect of ${\omega}3$-fatty acid desaturase (fat-1) gene expression on invasion and tumorigenicity in human tongue SCC cells and the molecular mechanism of its action. Docosahexaenoic acid (DHA) treatment inhibited in vitro invasion in a dose-dependent manner. In zymography, matrix metalloproteinase-9 (MMP-9) and Matrix metallopeptidase-2 (MMP-2) activities were reduced, and MMP-9 and MMP-2 promoter activities were inhibited by the DHA treatment. In addition, cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) promoter reporter activities were inhibited in SCC-4 and SCC-9 cells after the DHA treatment. To investigate the effect of a high level of endogenous ${\omega}3$ fatty acids, a stable SCC-9 cell line expressing the ${\omega}3$-desaturase gene (fSCC-9sc) was generated. The growth rate and colony-forming capacity of fSCC-9sc were remarkably decreased as compared with those of fSCC-9cc. Likewise, the tumor size and volume of fSCC-9sc implanted into nude mice were significantly inhibited, with increases in the cell death index. Furthermore, a transwell chamber invasion assay showed a reduction in cell invasion of the fSCC-9sc lines when compared with that of the fSCC-9cc line. These findings suggested that fat-1 gene expression inhibited tumorigenicity, as well as invasion in human tongue SCC cells. Thus, utilization of ${\omega}3$ fatty acids may represent a promising therapeutic approach for chemoprevention and the treatment of human tongue SCCs.

키워드

참고문헌

  1. Bond, M., Chase, A. J., Baker, A. H. and Newby, A. C. 2001. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res. 50, 556-565. https://doi.org/10.1016/S0008-6363(01)00220-6
  2. Boudreau, M. D., Sohn, K. H., Rhee, S. H., Lee, S. W., Hunt, J. D. and Hwang, D. H. 2001. Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: mediation through cyclooxygenase-independent pathways. Cancer Res. 61, 1386-1391.
  3. Bougnoux, P. 1999. n-3 polyunsaturated fatty acids and cancer. Curr. Opin. Clin. Nutr. Metab. Care 2, 121-126. https://doi.org/10.1097/00075197-199903000-00005
  4. Bu, X., Zhao, C. and Dai, X. 2011. Involvement of COX-2/PGE(2) pathway in the upregulation of MMP-9 expression in pancreatic cancer. Gastroenterol. Res. Pract. 2011, 214269.
  5. Calviello, G., Di Nicuolo, F., Gragnoli, S., Piccioni, E., Serini, S., Maggiano, N., Tringali, G., Navarra, P., Ranelletti, F. O. and Palozza, P. 2004. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 25, 2303-2310. https://doi.org/10.1093/carcin/bgh265
  6. Chen, P. N., Hsieh, Y. S., Chiang, C. L., Chiou, H. L., Yang, S. F. and Chu, S. C. 2006. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J. Dent. Res. 85, 220-225. https://doi.org/10.1177/154405910608500303
  7. Cheng, A. S., Chan, H. L., To, K. F., Leung, W. K., Chan, K. K., Liew, C. T. and Sung, J. J. 2004. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma. Int. J. Oncol. 24, 853-860.
  8. Collett, E. D., Davidson, L. A., Fan, Y. Y., Lupton, J. R. and Chapkin, R. S. 2001. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am. J. Physiol. Cell Physiol. 280, C1066-1075.
  9. Eberhardt, W., Huwiler, A., Beck, K. F., Walpen, S. and Pfeilschifter, J. 2000. Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J. Immunol. 165, 5788-5797. https://doi.org/10.4049/jimmunol.165.10.5788
  10. Franken, N. A., Rodermond, H. M., Stap, J., Haveman, J. and van Bree, C. 2006. Clonogenic assay of cells in vitro. Nat. Protoc. 1, 2315-2319. https://doi.org/10.1038/nprot.2006.339
  11. Ge, Y., Chen, Z., Kang, Z. B., Cluette-Brown, J., Laposata, M. and Kang, J. X. 2002. Effects of adenoviral gene transfer of C. elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cells. Anticancer Res. 22, 537-543.
  12. Hammamieh, R., Chakraborty, N., Miller, S. A., Waddy, E., Barmada, M., Das, R., Peel, S. A., Day, A. A. and Jett, M. 2007. Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Breast Cancer Res. Treat. 101, 7-16. https://doi.org/10.1007/s10549-006-9269-x
  13. Hong, T. H., Kim, H., Shin, S., Jing, K., Jeong, S., Lim, H., Yun, D. H., Jeong, K. E., Lee, M. R., Park, J. I., Kweon, G. R., Park, S. K., Hwang, B. D. and Lim, K. 2013. Cytotoxic mechanism of docosahexaenoic acid in human oral cancer cells. J. Life Sci. 23, 689-697. https://doi.org/10.5352/JLS.2013.23.5.689
  14. Hwang, J. Y., Lee, G. H., Yoo, J. H., Lee, S. Y. and Yang, H. S. 2008. Combined expression of COX-2, MMP-9, p53 and VEGF in squamous cell carcinoma of the head and neck. Kor. J. Otorhinolaryngol-Head Neck Surg. 51, 1036-1042.
  15. Jing, K., Shin, S., Jeong, S., Kim, S., Song, K. S., Park, J. H., Heo, J. Y., Seo, K. S., Park, S. K., Kweon, G. R., Wu, T., Park, J. I. and Lim, K. 2014. Docosahexaenoic acid induces the degradation of HPV E6/E7 oncoproteins by activating the ubiquitin-proteasome system. Cell Death Dis. 5, e1524. https://doi.org/10.1038/cddis.2014.477
  16. Jing, K., Song, K. S., Shin, S., Kim, N., Jeong, S., Oh, H. R., Park, J. H., Seo, K. S., Heo, J. Y., Han, J., Park, J. I., Han, C., Wu, T., Kweon, G. R., Park, S. K., Yoon, W. H., Hwang, B. D. and Lim, K. 2011. Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53. Autophagy 7, 1348-1358. https://doi.org/10.4161/auto.7.11.16658
  17. Jung, K. W., Won, Y. J., Kong, H. J., Lee, E. S. and Community of Population-based Regional Cancer, R. 2018. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015. Cancer Res Treat.
  18. Konstantinopoulos, P. A., Vandoros, G. P., Karamouzis, M. V., Gkermpesi, M., Sotiropoulou-Bonikou, G. and Papavassiliou, A. G. 2007. EGF-R is expressed and AP-1 and NF-kappaB are activated in stromal myofibroblasts surrounding colon adenocarcinomas paralleling expression of COX-2 and VEGF. Cell Oncol. 29, 477-482.
  19. Larsson, S. C., Kumlin, M., Ingelman-Sundberg, M. and Wolk, A. 2004. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am. J. Clin. Nutr. 79, 935-945. https://doi.org/10.1093/ajcn/79.6.935
  20. Leng, J., Han, C., Demetris, A. J., Michalopoulos, G. K. and Wu, T. 2003. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology 38, 756-768.
  21. Lim, K., Han, C., Dai, Y., Shen, M. and Wu, T. 2009. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. Mol. Cancer Ther. 8, 3046-3055. https://doi.org/10.1158/1535-7163.MCT-09-0551
  22. Lim, K., Han, C., Xu, L., Isse, K., Demetris, A. J. and Wu, T. 2008. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids. Cancer Res. 68, 553-560. https://doi.org/10.1158/0008-5472.CAN-07-2295
  23. Liu, G., Bibus, D. M., Bode, A. M., Ma, W. Y., Holman, R. T. and Dong, Z. 2001. Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells. Proc. Natl. Acad. Sci. USA. 98, 7510-7515. https://doi.org/10.1073/pnas.131195198
  24. Lu, Y., Nie, D., Witt, W. T., Chen, Q., Shen, M., Xie, H., Lai, L., Dai, Y. and Zhang, J. 2008. Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3 beta phosphorylation. Mol. Cancer Ther. 7, 3203-3211. https://doi.org/10.1158/1535-7163.MCT-08-0494
  25. Minami, Y., Nishino, Y., Tsubono, Y., Tsuji, I. and Hisamichi, S. 2006. Increase of colon and rectal cancer incidence rates in Japan: trends in incidence rates in Miyagi Prefecture, 1959-1997. J. Epidemiol. 16, 240-248. https://doi.org/10.2188/jea.16.240
  26. Mukutmoni-Norris, M., Hubbard, N. E. and Erickson, K. L. 2000. Modulation of murine mammary tumor vasculature by dietary n-3 fatty acids in fish oil. Cancer Lett. 150, 101-109. https://doi.org/10.1016/S0304-3835(99)00380-8
  27. Nagase, H. and Woessner, J. F., Jr. 1999. Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494. https://doi.org/10.1074/jbc.274.31.21491
  28. Narayanan, B. A., Narayanan, N. K., Desai, D., Pittman, B. and Reddy, B. S. 2004. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis (methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells. Carcinogenesis 25, 2443-2449. https://doi.org/10.1093/carcin/bgh252
  29. Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K. and Hayakawa, T. 1992. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267, 21712-21719.
  30. Paulsen, J. E., Elvsaas, I. K., Steffensen, I. L. and Alexander, J. 1997. A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse. Carcinogenesis 18, 1905-1910. https://doi.org/10.1093/carcin/18.10.1905
  31. Rose, D. P. and Connolly, J. M. 1999. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther. 83, 217-244. https://doi.org/10.1016/S0163-7258(99)00026-1
  32. Siegel, R. L., Miller, K. D. and Jemal, A. 2018. Cancer statistics, 2018. CA Cancer J. Clin. 68, 7-30. https://doi.org/10.3322/caac.21442
  33. Song, K. S., Jing, K., Kim, J. S., Yun, E. J., Shin, S., Seo, K. S., Park, J. H., Heo, J. Y., Kang, J. X., Suh, K. S., Wu, T., Park, J. I., Kweon, G. R., Yoon, W. H., Hwang, B. D. and Lim, K. 2011. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling. Pancreatology 11, 574-584. https://doi.org/10.1159/000334468
  34. Suzuki, K., Enghild, J. J., Morodomi, T., Salvesen, G. and Nagase, H. 1990. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29, 10261-10270. https://doi.org/10.1021/bi00496a016
  35. Tong, Q., Zheng, L., Lin, L., Li, B., Wang, D., Huang, C., Matuschak, G. M. and Li, D. 2006. Participation of the PI-3K/Akt-NF-kappa B signaling pathways in hypoxia-induced mitogenic factor-stimulated Flk-1 expression in endothelial cells. Respir Res. 7, 101. https://doi.org/10.1186/1465-9921-7-101
  36. Xia, S., Lu, Y., Wang, J., He, C., Hong, S., Serhan, C. N. and Kang, J. X. 2006. Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids. Proc. Natl. Acad. Sci. USA. 103, 12499-12504. https://doi.org/10.1073/pnas.0605394103
  37. Xia, S. H., Wang, J. and Kang, J. X. 2005. Decreased n-6/n-3 fatty acid ratio reduces the invasive potential of human lung cancer cells by downregulation of cell adhesion/invasion-related genes. Carcinogenesis 26, 779-784. https://doi.org/10.1093/carcin/bgi019
  38. Yao, L., Han, C., Song, K., Zhang, J., Lim, K. and Wu, T. 2015. Omega-3 polyunsaturated fatty acids upregulate 15-PGDH expression in cholangiocarcinoma cells by inhibiting miR-26a/b expression. Cancer Res. 75, 1388-1398.
  39. Yeh, C. B., Hsieh, M. J., Hsieh, Y. H., Chien, M. H., Chiou, H. L. and Yang, S. F. 2012. Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity. PLoS One 7, e31055. https://doi.org/10.1371/journal.pone.0031055
  40. Yoon, W. H., Jung, Y. J., Kim, T. D., Li, G., Park, B. J., Kim, J. Y., Lee, Y. C., Kim, J. M., Park, J. I., Park, H. D., No, Z. S., Lim, K., Hwang, B. D. and Kim, Y. S. 2004. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis. Clin. Cancer Res. 10, 4517-4526. https://doi.org/10.1158/1078-0432.CCR-04-0084
  41. Yun, E. J., Song, K. S., Shin, S., Kim, S., Heo, J. Y., Kweon, G. R., Wu, T., Park, J. I. and Lim, K. 2016. Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases. Oncotarget 7, 49961-49971.
  42. Zhang, X., Liu, Y., Gilcrease, M. Z., Yuan, X. H., Clayman, G. L., Adler-Storthz, K. and Chen, Z. 2002. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 95, 1663-1672. https://doi.org/10.1002/cncr.10837